BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31027286)

  • 1. Distinct Binding Dynamics, Sites and Interactions of Fullerene and Fullerenols with Amyloid-β Peptides Revealed by Molecular Dynamics Simulations.
    Liu Z; Zou Y; Zhang Q; Chen P; Liu Y; Qian Z
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of a water-soluble fullerene derivative with amyloid-β protofibrils: dynamics, binding mechanism, and the resulting salt-bridge disruption.
    Zhou X; Xi W; Luo Y; Cao S; Wei G
    J Phys Chem B; 2014 Jun; 118(24):6733-41. PubMed ID: 24857343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment.
    Xie L; Luo Y; Lin D; Xi W; Yang X; Wei G
    Nanoscale; 2014 Aug; 6(16):9752-62. PubMed ID: 25004796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fullerenol C60(OH)16 prevents amyloid fibrillization of Aβ40-in vitro and in silico approach.
    Bednarikova Z; Huy PD; Mocanu MM; Fedunova D; Li MS; Gazova Z
    Phys Chem Chem Phys; 2016 Jul; 18(28):18855-67. PubMed ID: 27350395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential binding of fullerene and fullerenol with the N-terminal and middle regions of amyloid beta peptide: an in silico investigation.
    Pandya V; Baweja L; Dhawan A
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):71-73. PubMed ID: 29593399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity.
    Jin Y; Sun Y; Lei J; Wei G
    Phys Chem Chem Phys; 2018 Jun; 20(25):17208-17217. PubMed ID: 29900443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.
    Zou Y; Qian Z; Chen Y; Qian H; Wei G; Zhang Q
    ACS Chem Neurosci; 2019 Mar; 10(3):1585-1594. PubMed ID: 30605312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ
    Li F; Zhan C; Dong X; Wei G
    Phys Chem Chem Phys; 2021 Sep; 23(34):18843-18854. PubMed ID: 34612422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational design and evaluation of β-sheet breaker peptides for destabilizing Alzheimer's amyloid-β
    Shuaib S; Narang SS; Goyal D; Goyal B
    J Cell Biochem; 2019 Oct; 120(10):17935-17950. PubMed ID: 31162715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of fullerenes to amyloid beta fibrils: size matters.
    Huy PD; Li MS
    Phys Chem Chem Phys; 2014 Oct; 16(37):20030-40. PubMed ID: 25123396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into Molecular Mechanisms of EGCG and Apigenin on Disrupting Amyloid-Beta Protofibrils Based on Molecular Dynamics Simulations.
    Fang M; Zhang Q; Guan P; Su K; Wang X; Hu X
    J Phys Chem B; 2022 Oct; 126(41):8155-8165. PubMed ID: 36219848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphilic surface chemistry of fullerenols is necessary for inhibiting the amyloid aggregation of alpha-synuclein NACore.
    Sun Y; Kakinen A; Zhang C; Yang Y; Faridi A; Davis TP; Cao W; Ke PC; Ding F
    Nanoscale; 2019 Jun; 11(24):11933-11945. PubMed ID: 31188372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils.
    Martin TD; Malagodi AJ; Chi EY; Evans DG
    J Phys Chem B; 2019 Jan; 123(3):551-560. PubMed ID: 30571122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into Aβ
    Saini RK; Shuaib S; Goyal B
    J Mol Recognit; 2017 Dec; 30(12):. PubMed ID: 28850770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into the inhibition of early stages of Aβ peptide aggregation and destabilization of Alzheimer's Aβ protofibril by dipeptide D-Trp-Aib: A molecular modelling approach.
    Mohammed AA; Barale SS; Kamble SA; Paymal SB; Sonawane KD
    Int J Biol Macromol; 2023 Jul; 242(Pt 3):124880. PubMed ID: 37217059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Insight into the Mechanisms of Dopamine in Disrupting Aβ Protofibrils and Inhibiting Aβ Aggregation.
    Chen Y; Li X; Zhan C; Lao Z; Li F; Dong X; Wei G
    ACS Chem Neurosci; 2021 Nov; 12(21):4007-4019. PubMed ID: 34472835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of a multifunctional di-triazole derivative with Alzheimer's Aβ
    Kaur A; Shuaib S; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Jan; 22(3):1543-1556. PubMed ID: 31872820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
    Singh K; Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.